Edap TMS SA (FOCL) stock

Add to watchlist

Add holding +

NASDAQ: FOCL Nasdaq Health Care Equipment Next results ~November 5, 2026

Edap TMS SA is a US-listed company in the health care equipment industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

~$1.8

Forward price-to-sales vs peers

Base case. Range ~$1.8–$6.8. Next year's consensus sales per share times peers' typical forward price-to-sales; only when earnings are negative.

Price vs value

No Buy/Hold/Sell rating is issued: limited reported history: available models are shown without a Buy/Hold/Sell rating.

Edap TMS SA valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

Insiders8 buying, 0 selling9 purchases and 0 sales by directors and officers, last 12 monthsInsider trades
Funds15 adding, 10 cuttingOf 3 active managers that changed their stake, 3 added; quarter to June 30, 2026Fund buyers and sellers

The Fundamentalytics view

Next results ~November 5, 2026 (estimated)

Current signal Several insiders buying shares: 8 insiders bought shares in the open market in the past 90 days, according to their Form 4 filings.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

Nothing in Edap TMS SA's latest figures clears our strength thresholds.

Things to watch

Volatile shares. Over the past year the shares showed annualised volatility of 69% and a beta of 0.8 against the S&P 500.
Missing expectations. Earnings per share fell short of the consensus estimate in 3 of the last four quarters.

Latest results

Earnings per share: -$0.24 against an average estimate of -$0.20: missed by 19.1%
Share reaction: +0.2% in the first session after the results on August 13, 2026, against +0.5% for the S&P 500
Next report: November 5, 2026; average EPS estimate -$0.26

Edap TMS SA's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

1 day+3.8%
1 week+2.6%
1 month+3.3%
This year+31.9%
1 year+102.8%
5 years-27.7%
S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Earnings

Last results: August 13, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

August 19, 2026Announcement

Edap TMS SA disclosed a material event

SEC 8-KRead source ↗
August 14, 2026Agreement

Edap TMS SA entered a material agreement

SEC 8-KRead source ↗
August 13, 2026Results

Edap TMS SA reported results

SEC 8-KRead source ↗
August 11, 2026Results

Edap TMS SA reported results; made a public disclosure; disclosed a material event

SEC 8-KRead source ↗

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Edap TMS SA valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: limited reported history: available models are shown without a Buy/Hold/Sell rating.

Valuation models

We value Edap TMS SA as an operating company, with every model that fits that kind of business. Cost of equity 9%: the 10-year Treasury yield (4.9%) plus a beta of 0.89 times a 4.5% equity risk premium.

Value per share by model
Model	Value per share	In the combined value?
Growth cash-flow model Revenue for this year and next from analysts' consensus, then growth fading to 2.5%; the operating margin moving to profitable peers'; investment needed per dollar of growth from peers; reduced by a failure probability. For young or fast-growing companies. The starting margin is normalized to between -100% and 60%; net margin is a proxy when operating income is not tagged. Uses analysts' consensus estimates (third-party data), not our forecasts.	—	Does not apply: no revenue, margin or share count to start from
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings.	—	Does not apply: no twelve-month earnings or share count in the filings yet
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years.	—	Does not apply: no twelve-month earnings or share count in the filings yet
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns.	—	Does not apply: no twelve-month earnings or share count in the filings yet
Forward price-to-sales vs peers Next year's consensus sales per share times peers' typical forward price-to-sales; only when earnings are negative. Uses analysts' consensus estimates (third-party data), not our forecasts.	~$1.8 ~$2.0–$6.8	Included, half weight
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable.	—	Does not apply: revenue and margins don't support a positive value
Combined value Weighted average of the models that apply: the primary model (growth cash-flow model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out.	~$1.8 ~$1.8–$6.8	1 model

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Edap TMS SA with Health Care Equipment in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 5, 2026, after the close. Analysts expect revenue of $12m and EPS of −$0.26 (range −$0.26 to −$0.26) for the quarter.

Analysts' consensus

Edap TMS SA: consensus estimates
Fiscal year	EPS	Growth	Revenue	Growth
Current	−$1.04	−30%	$52m	−28%
Next	−$0.67	+36%	$70m	+34%

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +28.4% on 90 days ago. In the last 30 days, 0 analysts raised Edap TMS SA's forecast and 0 cut it.

Consensus EPS forecast Edap TMS SA, last 90 days

Average of analysts' published estimates (third-party data).

View chart data

Period	Current fiscal year	Next fiscal year
90 days ago	−$0.81	−$0.58
60 days ago	−$0.81	−$0.60
30 days ago	−$1.04	−$0.67
7 days ago	−$1.04	−$0.67
Now	−$1.04	−$0.67

Earnings against estimates

Edap TMS SA: reported EPS against the consensus estimate
Quarter to	Estimate	Actual	Surprise
Jun 2026	−$0.20	−$0.24	−19.1%
Mar 2026	−$0.21	−$0.24	−11.6%
Dec 2025	−$0.16	−$0.25	−62.4%
Sept 2025	−$0.26	−$0.15	+42.8%

Adjusted EPS as companies report it, against the average analyst estimate.

Analyst recommendations

5 analysts, Oct 2026

Buy360%

Hold240%

Sell00%

Monthly trend

Oct 2026325
Sep 2026325
Aug 2026325
Jul 2026325

Counts of recommendations published by analysts covering Edap TMS SA, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest: 0.9%
Days to cover: 4.64
Short interest, 1 month: +36%
Held by institutions: 40%
Held by insiders: 5.1%
Employees: 289

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Return and risk by year

Edap TMS SA: yearly return, monthly win rate and worst fall against the S&P 500
Calendar year	2021	2022	2023	2024	2025	2026 to date
Return
FOCL	+16%	+78%	−51%	−58%	+49%	+32%
Industry peers (median)	−9%	−37%	−8%	−19%	−16%	−15%
S&P 500	+29%	−18%	+26%	+25%	+18%	+11%
Months that ended higher
FOCL	42%	67%	25%	25%	58%	64%
S&P 500	75%	42%	67%	75%	75%	46%
Largest fall from a high during the year
FOCL	−50%	−20%	−67%	−75%	−56%	−37%
S&P 500	−5%	−25%	−10%	−8%	−19%	−9%

Worst fall since November 2, 2015: 90% from March 3, 2023 to August 6, 2025. Getting back needed a 899% gain, and the shares have not yet recovered.

Price behaviour

52-week range: $1.99 – $6.34
From 52-week high: −31.5%
vs 50-day average: +2.0%
vs 200-day average: −1.6%
Volatility (1 year): 69%
Beta vs S&P 500: 0.81

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day: 3 up, 2 down
After a week: 2 up, 3 down
After a month: 2 up, 3 down

Edap TMS SA: share-price change after each results release
Results released	Next day	S&P 500 next day	5 days	21 days
August 13, 2026	+0.2%	+0.5%	−10.7%	−13.5%
August 11, 2026	−21.9%	−0.1%	−29.9%	−31.6%
May 7, 2026	+14.7%	+0.5%	+14.7%	+27.8%
March 25, 2026	−3.6%	−1.2%	−9.7%	−17.6%
January 12, 2026	+11.1%	0.0%	+0.3%	+33.2%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Fundamentals

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms . Generated November 3, 2026. Definitions in our methodology.

Where the revenue comes from

Fiscal year to December 31, 2025

Segments
Line of business	Revenue	Share	YoY
High Intensity Focused Ultrasound HIFU	$37.4M	53.0%	▲ 44.8%
Distribution Division	$25.7M	36.5%	▼ 24.1%
Lithotripsy Eswl	$7.5M	10.6%	▼ 23.2%

Products and services
Line of business	Revenue	Share	YoY
Manufactured Product Other	$48.9M	69.3%	▲ 2.6%
Parts and Services	$11.3M	16.1%	▼ 16.0%
HIFU Treatments and Devices Leased	$10.3M	14.6%	▲ 24.9%

Geography
Region	Revenue	Share	YoY
United States	$28.5M	40.4%	▲ 44.6%
Asia	$19.6M	27.7%	▼ 5.1%
Other Geographical Areas	$17.8M	25.3%	▲ 5.6%
France	$4.6M	6.5%	▼ 62.3%

From Edap TMS SA's 10-K filed March 25, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling

Reported value: $79.5M
Institutions reporting: 37
Shares held vs prior quarter: ▲ 6.9%
Positions opened / closed: 6 / 5

15 bought 10 sold

Top buyers and sellers, Q2 2026: 15 institutions bought and 10 sold ; the biggest buyer was Flax Pond Capital, LLC (+742K shares) and the biggest seller UBS Group AG (−51K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager	Value	Shares	Share of 13F value	Shares QoQ
Soleus Capital Management, L.P.	$37.9M	7.3M	47.6%	0.0%
Morgan Stanley	$17.3M	3.3M	21.7%	▼ 0.3%
Rock Springs Capital Management LP	$7.2M	1.4M	9.0%	▲ 0.6%
Flax Pond Capital, LLC	$6.8M	1.5M	8.5%	▲ 94.7%
Bruce & Co., Inc.	$2.3M	439K	2.9%	0.0%
Parkman Healthcare Partners LLC	$802,030	155K	1.0%	0.0%
Essex Investment Management Co LLC	$756,306	146K	1.0%	New
Cahill Financial Advisors Inc	$699,093	135K	0.9%	0.0%
Us Bancorp	$634,550	123K	0.8%	▲ 2.9%
UBS Group AG	$613,286	118K	0.8%	▼ 30.2%
Sage Mountain Advisors LLC	$518,000	100K	0.7%	0.0%
Leonteq Securities AG	$492,048	95K	0.6%	0.0%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Edap TMS SA's complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart

Insider purchases History → $593,200 9 trades by 8 insiders, last 12 months Insider sales History → $0 0 trades by 0 insiders

Net ▲ $593,200 net buying

Recent insider open-market transactions
Insider	Date	Trade	Shares	Price	Value
Annen Steven SVP, Marketing & Product Mgmt.	August 14, 2026	Buy	5,000	$4.75	$23,750
Shah Sanket General Counsel & Corp Sec	August 14, 2026	Buy	5,000	$4.75	$23,750
Rhodes Ryan Chief Executive Officer	August 14, 2026	Buy	21,000	$4.75	$99,750
Willsey Lance Director	August 14, 2026	Buy	50,000	$4.75	$237,500
Mobeck Kenneth S. Chief Financial Officer	August 14, 2026	Buy	5,000	$4.75	$23,750
Levine Joshua Director	August 14, 2026	Buy	10,000	$4.75	$47,500
Schulz Fran Director	August 14, 2026	Buy	10,000	$4.75	$47,500
Horn David R. Director	August 14, 2026	Buy	10,000	$4.75	$47,500
Levine Joshua Director	May 11, 2026	Buy	10,000	$4.22	$42,200

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

August 13, 2026
August 11, 2026
May 7, 2026
March 25, 2026
January 12, 2026

Recent SEC filings

8-K Current report August 19, 2026
10-Q Quarterly report August 14, 2026
8-K Current report August 14, 2026
8-K Current report August 13, 2026
8-K Current report August 11, 2026
8-K Current report June 26, 2026
8-K Current report June 1, 2026
8-K Current report May 29, 2026

Data status

When each part of this page on Edap TMS SA was last updated.

Data	Last updated	Source
Share price	November 2, 2026	Exchange closing prices
News and updates	October 31, 2026, 7:55pm ET	Company releases and SEC 8-K filings
Analyst estimates	October 31, 2026, 9:26am ET	Aggregated analyst estimates
Valuation and scores	November 3, 2026, 9:17am ET	Our models, from the filed figures

How we build and check these figures: methodology and data sources.

Edap TMS SA in brief

What does Edap TMS SA do?: Edap TMS SA is a US-listed company in the health care equipment industry. Its financial year ends in December.
What is Edap TMS SA's stock ticker?: Edap TMS SA trades under the ticker FOCL on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
Who are Edap TMS SA's largest institutional shareholders?: By value reported in 13F filings for June 30, 2026, the largest reported holders are Soleus Capital Management, L.P., Morgan Stanley and Rock Springs Capital Management LP. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Are insiders buying or selling Edap TMS SA stock?: Over the last 12 months, Edap TMS SA's directors and officers reported 9 open-market purchases and 0 sales on Form 4. The insider trading page charts every trade.
When is Edap TMS SA's next earnings date?: Around November 5, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Edap TMS SA announces its own schedule.